Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • REGEN-COV

    - PMLiVE

    Regeneron’s Libtayo receives EC approval for skin cancer

    Phase 3 trial results showed the drug significantly improved disease-free survival

    - PMLiVE

    Invivyd working with FDA towards potential Biologics License Application for COVID-19

    The company plans head-to-head safety evaluation with COVID-19 vaccine, pending regulatory alignment

    - PMLiVE

    FDA approves Pfizer and BioNTech’s jab for COVID-19

    Globally, five billion doses of the companies’ vaccine have been distributed

    - PMLiVE

    Moderna’s LP.8.1-adapted COVID-19 vaccine recommended by CHMP

    Global health authorities have recommended that vaccines for the 2025-2026 season should target LP.8.1

    - PMLiVE

    Sanofi/Regeneron’s Dupixent granted FDA approval for bullous pemphigoid

    Around 27,000 adults in the US are living with uncontrolled cases of the chronic skin disease

    - PMLiVE

    Sanofi/Regeneron share results for Dupixent in atopic dermatitis patients with darker skin tones

    These are the first clinical study results for the drug in a large population of patients with darker skin tones

    regeneron headquarters

    Regeneron’s bispecific antibody Lynozyfic approved by EC to treat multiple myeloma

    More than 35,000 new cases of the blood cancer are diagnosed in Europe every year

    - PMLiVE

    Sanofi/Regeneron’s Dupixent granted FDA approval for chronic spontaneous urticaria

    More than 300,000 people in the US are living with uncontrolled cases of the inflammatory skin disease

    - PMLiVE

    EC approves CSL/Arcturus’ self-amplifying mRNA COVID-19 vaccine Kostaive

    Kostaive is designed to instruct the body to make more mRNA to boost immune response

    - PMLiVE

    Sanofi and Regeneron’s Dupixent granted FDA priority review for bullous pemphigoid

    Approximately 27,000 adults in the US are living with uncontrolled cases of the skin disease

    - PMLiVE

    WHO urges US to ‘reconsider’ withdrawal from global health organisation

    President Donald Trump said the agency mishandled the COVID-19 pandemic and other global health crises

    - PMLiVE

    Sanofi receives FDA fast track designation for COVID-19/flu combination vaccines

    The combined vaccine approach could simplify immunisation practices and lead to higher uptake

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links